Livforsakringsbolaget Skandia Omsesidigt Has Trimmed Its Vertex Pharmaceuticals (VRTX) Holding by $441,600; Netflix (NFLX) Stake Has Upped by Bedrijfstakpensioenfonds Voor De Media Pno

Netflix, Inc. (NASDAQ:NFLX) Logo

Bedrijfstakpensioenfonds Voor De Media Pno increased its stake in Netflix Inc (NFLX) by 35.14% based on its latest 2018Q3 regulatory filing with the SEC. Bedrijfstakpensioenfonds Voor De Media Pno bought 13,000 shares as the company’s stock declined 22.59% with the market. The institutional investor held 50,000 shares of the consumer services company at the end of 2018Q3, valued at $18.71 million, up from 37,000 at the end of the previous reported quarter. Bedrijfstakpensioenfonds Voor De Media Pno who had been investing in Netflix Inc for a number of months, seems to be bullish on the $156.07 billion market cap company. The stock decreased 0.69% or $2.5 during the last trading session, reaching $357.47. About 5.86M shares traded. Netflix, Inc. (NASDAQ:NFLX) has risen 45.63% since February 13, 2018 and is uptrending. It has outperformed by 45.63% the S&P500. Some Historical NFLX News: 07/03/2018 – Netflix is worth more than GE or Ford, and it’s creeping up on Disney:; 16/04/2018 – Netflix programming binge pays off with subscriber surge; 27/04/2018 – The Rain, Netflix – a post-apocalyptic Scandi horror; 22/03/2018 – Netflix has a new font and the company claims it’s going to save it millions; 08/03/2018 – The Obamas may be producing shows for Netflix soon, says report; 23/05/2018 – Deadline Hollywd: Jeffrey Tambor Back In Emmy Race; Netflix Submits `Arrested Development’ Role; 16/05/2018 – Hollywood Reporter: Exclusive: Amy Ryan replaces Sarah Paulson as ‘Lost Girls’ moves from Amazon to @Netflix; 16/04/2018 – Netflix Tops Revenue and Subscriber Estimates (Video); 08/04/2018 – Fortune: Netflix Could Pull Films From Cannes in Response to Competition Ban; 24/05/2018 – Netflix Tussles Disney for Crown; Autonomous Uber Fail: TMT Wrap

Livforsakringsbolaget Skandia Omsesidigt decreased its stake in Vertex Pharmaceuticals Inc (VRTX) by 50.36% based on its latest 2018Q3 regulatory filing with the SEC. Livforsakringsbolaget Skandia Omsesidigt sold 2,300 shares as the company’s stock declined 3.07% with the market. The institutional investor held 2,267 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $437,000, down from 4,567 at the end of the previous reported quarter. Livforsakringsbolaget Skandia Omsesidigt who had been investing in Vertex Pharmaceuticals Inc for a number of months, seems to be less bullish one the $47.45B market cap company. The stock increased 1.05% or $1.93 during the last trading session, reaching $185.94. About 429,871 shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 25.22% since February 13, 2018 and is uptrending. It has outperformed by 25.22% the S&P500. Some Historical VRTX News: 09/03/2018 – L3 management meets with bidders for Vertex divest; 08/05/2018 – Vertex Names Bernadette Pinamont Vice President of Tax Research; 09/03/2018 – Consolidated Research: 2018 Summary Expectations for Envision Healthcare, Taylor Morrison Home, Vertex Pharmaceuticals, ReShape; 09/04/2018 – Mass. governor defends Vertex drug pricing, saying ‘innovation is expensive’; 13/04/2018 – Vertex Opens Offices in Amsterdam and Frankfurt to Expand European Presence; 26/04/2018 – Vertex Pharmaceuticals Initiates Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People With Cystic Fibrosis; 04/05/2018 – L3’s Vertex sold for single-digit adjusted EBITDA multiple; 26/04/2018 – Vertex Initiates Phase 3 Studies of VX-445, Tezacaftor and lvacaftor as a Triple Combination Regimen for People with Cystic Fibrosis; 29/05/2018 – Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel; 26/04/2018 – STAT Plus: New York panel votes to lower the cost of a pricey Vertex drug for cystic fibrosis

Livforsakringsbolaget Skandia Omsesidigt, which manages about $840.55 million US Long portfolio, upped its stake in Mercer International Inc (NASDAQ:MERC) by 30,700 shares to 52,200 shares, valued at $877,000 in 2018Q3, according to the filing.

Since August 28, 2018, it had 0 insider buys, and 33 insider sales for $25.71 million activity. Another trade for 2,155 shares valued at $377,901 was sold by Arbuckle Stuart A. $207,926 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Graney Thomas. On Thursday, October 4 Parini Michael sold $814,215 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) or 4,250 shares. Sachdev Amit also sold $709,709 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares. Shares for $6.01M were sold by LEIDEN JEFFREY M. $573,182 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares were sold by Silva Paul M.

More notable recent Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) news were published by: Nasdaq.com which released: “VRTX Crosses Above Key Moving Average Level – Nasdaq” on November 27, 2018, also Nasdaq.com with their article: “Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates – Nasdaq” published on February 05, 2019, Benzinga.com published: “Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering – Benzinga” on February 06, 2019. More interesting news about Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) were released by: Nasdaq.com and their article: “Vertex (VRTX) Hits Fresh High: Is There Still Room to Run? – Nasdaq” published on August 30, 2018 as well as Seekingalpha.com‘s news article titled: “Vertex boots COO over “personal behavior” – Seeking Alpha” with publication date: January 23, 2019.

Investors sentiment decreased to 1.06 in Q3 2018. Its down 0.24, from 1.3 in 2018Q2. It worsened, as 42 investors sold VRTX shares while 192 reduced holdings. 73 funds opened positions while 176 raised stakes. 231.66 million shares or 2.06% less from 236.55 million shares in 2018Q2 were reported. 1,789 are held by Cullen Frost Bankers. Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 2,900 shares. Hillsdale Invest Mngmt Inc owns 2,810 shares. World Asset Mgmt Incorporated invested 0.16% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Clearbridge Limited Co has 0.02% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Brown Brothers Harriman accumulated 372 shares or 0% of the stock. 1.15M are held by Amer Century Cos. Patten Inc reported 0% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Retail Bank Of Montreal Can reported 309,881 shares or 0.05% of all its holdings. 122,795 are held by Aviva Pcl. Puzo Michael J has invested 0.22% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Daiwa Gru Inc reported 10,347 shares. Hl Fincl Ltd Liability Co accumulated 2,755 shares. Glenmede Trust Na holds 0% or 1,740 shares in its portfolio. Nordea Investment Ab holds 13,830 shares.

Among 31 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 26 have Buy rating, 0 Sell and 5 Hold. Therefore 84% are positive. Vertex Pharmaceuticals had 115 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Market Perform” rating by BMO Capital Markets on Thursday, April 7. The rating was upgraded by JMP Securities on Friday, March 17 to “Market Outperform”. Argus Research maintained the shares of VRTX in report on Thursday, February 4 with “Buy” rating. The firm earned “Buy” rating on Friday, September 29 by BTIG Research. Leerink Swann maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Tuesday, March 8 with “Outperform” rating. The firm earned “Buy” rating on Monday, September 25 by Jefferies. The company was maintained on Thursday, October 25 by Raymond James. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Buy” rating given on Wednesday, July 19 by Maxim Group. The firm has “Buy” rating given on Tuesday, September 26 by Leerink Swann. The stock has “Buy” rating by Maxim Group on Monday, March 5.

Investors sentiment decreased to 1.2 in 2018 Q3. Its down 0.11, from 1.31 in 2018Q2. It is negative, as 69 investors sold NFLX shares while 325 reduced holdings. 139 funds opened positions while 333 raised stakes. 313.38 million shares or 0.16% less from 313.87 million shares in 2018Q2 were reported. Everence Cap Mngmt Incorporated reported 9,792 shares. Intrust Retail Bank Na has 0.26% invested in Netflix, Inc. (NASDAQ:NFLX) for 2,764 shares. Shellback Capital Limited Partnership, Massachusetts-based fund reported 88,573 shares. St Johns Inv Mgmt Co Limited Liability Co, Florida-based fund reported 100 shares. Mark Asset Mngmt invested in 28,304 shares. Mitchell Mcleod Pugh Williams invested 0.37% in Netflix, Inc. (NASDAQ:NFLX). Moreover, Checchi Advisers Ltd Llc has 0.18% invested in Netflix, Inc. (NASDAQ:NFLX) for 4,061 shares. Massachusetts Service Ma reported 2.18M shares or 0.34% of all its holdings. Endurance Wealth Mgmt invested in 0% or 75 shares. Bbva Compass National Bank & Trust holds 2,225 shares. Smith Moore Co, Missouri-based fund reported 2,748 shares. First Republic Inv Management Inc reported 105,149 shares or 0.19% of all its holdings. Moreover, First Bank Of Hutchinson has 0.15% invested in Netflix, Inc. (NASDAQ:NFLX) for 719 shares. Telos Cap Mgmt invested in 0.22% or 1,863 shares. Marathon Trading Inv Mgmt Ltd accumulated 8,321 shares.

Among 59 analysts covering Netflix (NASDAQ:NFLX), 43 have Buy rating, 2 Sell and 14 Hold. Therefore 73% are positive. Netflix had 314 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Netflix, Inc. (NASDAQ:NFLX) has “Buy” rating given on Friday, August 28 by Wunderlich. Bernstein maintained the stock with “Buy” rating in Friday, March 9 report. Nomura maintained Netflix, Inc. (NASDAQ:NFLX) rating on Monday, July 17. Nomura has “Buy” rating and $175 target. The rating was maintained by Axiom Capital with “Sell” on Tuesday, October 18. The stock of Netflix, Inc. (NASDAQ:NFLX) has “Overweight” rating given on Friday, April 1 by Atlantic Securities. Oppenheimer maintained Netflix, Inc. (NASDAQ:NFLX) rating on Thursday, October 15. Oppenheimer has “Outperform” rating and $130 target. The rating was maintained by Morgan Stanley on Tuesday, October 18 with “Overweight”. FBR Capital maintained Netflix, Inc. (NASDAQ:NFLX) on Thursday, October 15 with “Outperform” rating. Loop Capital maintained Netflix, Inc. (NASDAQ:NFLX) rating on Thursday, October 26. Loop Capital has “Buy” rating and $237 target. The firm has “Hold” rating given on Tuesday, September 1 by Vetr.

More notable recent Netflix, Inc. (NASDAQ:NFLX) news were published by: Benzinga.com which released: “Dan Nathan Is A Seller Of Netflix Ahead Of Earnings (NASDAQ:NFLX) – Benzinga” on January 17, 2019, also Nasdaq.com with their article: “Northrop Grumman, BlackRock Capital, Facebook, Netflix and Google highlighted as Zacks Bull and Bear of the Day – Nasdaq” published on February 01, 2019, Nasdaq.com published: “Netflix Greenlights Second Season of The Kominsky Method – Nasdaq” on January 21, 2019. More interesting news about Netflix, Inc. (NASDAQ:NFLX) were released by: Nasdaq.com and their article: “3 Reasons It May Be Time to Cancel Netflix – Nasdaq” published on February 10, 2019 as well as Seekingalpha.com‘s news article titled: “Netflix In 2020 – Seeking Alpha” with publication date: January 30, 2019.

Bedrijfstakpensioenfonds Voor De Media Pno, which manages about $623.83 million US Long portfolio, decreased its stake in Microsoft Corp (NASDAQ:MSFT) by 46,000 shares to 400,000 shares, valued at $45.75M in 2018Q3, according to the filing. It also reduced its holding in Fmc Corp (NYSE:FMC) by 30,000 shares in the quarter, leaving it with 130,000 shares, and cut its stake in Mastercard Inc (NYSE:MA).

Since August 20, 2018, it had 0 buys, and 27 selling transactions for $148.07 million activity. On Tuesday, October 16 HALEY TIMOTHY M sold $7.36 million worth of Netflix, Inc. (NASDAQ:NFLX) or 21,882 shares. The insider BARTON RICHARD N sold 700 shares worth $237,279. $345,180 worth of Netflix, Inc. (NASDAQ:NFLX) shares were sold by WELLS DAVID B. 63,147 shares were sold by HASTINGS REED, worth $15.23M. Shares for $899,150 were sold by Sweeney Anne M.

Netflix, Inc. (NASDAQ:NFLX) Institutional Positions Chart